FDA Import Refusal SCS-7518890-8/11/1 — Eli Lilly Italia SPA
The FDA refused shipment SCS-7518890-8/11/1 from Eli Lilly Italia SPA (Italy) on Jan 13, 2025. The refused product falls under Drugs and Biologics — IXEKIZUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 13, 2025
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 58MCY11 IXEKIZUMAB
- Charges
- 75